| Diabetes and cancer P Vigneri, F Frasca, L Sciacca, G Pandini, R Vigneri Endocrine-related cancer 16 (4), 1103-1123, 2009 | 1416 | 2009 |
| Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells C Bellodi, MR Lidonnici, A Hamilton, GV Helgason, AR Soliera, ... The Journal of clinical investigation 119 (5), 1109-1123, 2009 | 693 | 2009 |
| The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts Experts in Chronic Myeloid Leukemia Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013 | 657 | 2013 |
| Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features G Bunone, P Vigneri, L Mariani, S Butó, P Collini, S Pilotti, MA Pierotti, ... The American journal of pathology 155 (6), 1967-1976, 1999 | 543 | 1999 |
| Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase P Vigneri, JYJ Wang Nature medicine 7 (2), 228-234, 2001 | 441 | 2001 |
| The changing epidemiology of thyroid cancer: why is incidence increasing? R Vigneri, P Malandrino, P Vigneri Current opinion in oncology 27 (1), 1-7, 2015 | 416 | 2015 |
| Iodide symporter gene expression in human thyroid tumors F Arturi, D Russo, M Schlumberger, JA du Villard, B Caillou, P Vigneri, ... The Journal of Clinical Endocrinology & Metabolism 83 (7), 2493-2496, 1998 | 248 | 1998 |
| RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. I Bongarzone, P Vigneri, L Mariani, P Collini, S Pilotti, MA Pierotti Clinical cancer research: an official journal of the American Association …, 1998 | 243 | 1998 |
| Cancer stem cells and chemosensitivity M Maugeri-Saccà, P Vigneri, R De Maria Clinical Cancer Research 17 (15), 4942-4947, 2011 | 242 | 2011 |
| Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma I Bongarzone, L Fugazzola, P Vigneri, L Mariani, P Mondellini, F Pacini, ... The Journal of Clinical Endocrinology & Metabolism 81 (5), 2006-2009, 1996 | 235 | 1996 |
| The insulin/IGF system in colorectal cancer development and resistance to therapy PG Vigneri, E Tirrò, MS Pennisi, M Massimino, S Stella, C Romano, ... Frontiers in oncology 5, 230, 2015 | 192 | 2015 |
| Vγ9Vδ2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells M D’Asaro, C La Mendola, D Di Liberto, V Orlando, M Todaro, M Spina, ... The Journal of Immunology 184 (6), 3260-3268, 2010 | 184 | 2010 |
| Heavy metals in the volcanic environment and thyroid cancer R Vigneri, P Malandrino, F Gianì, M Russo, P Vigneri Molecular and cellular endocrinology 457, 73-80, 2017 | 157 | 2017 |
| Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland S Pilotti, P Collini, L Mariani, M Placucci, I Bongarzone, P Vigneri, ... The American journal of surgical pathology 21 (12), 1466-1473, 1997 | 154 | 1997 |
| AKT inhibitors: new weapons in the fight against breast cancer? F Martorana, G Motta, G Pavone, L Motta, S Stella, SR Vitale, L Manzella, ... Frontiers in pharmacology 12, 662232, 2021 | 153 | 2021 |
| Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma D Russo, S Tumino, F Arturi, P Vigneri, G Grasso, A Pontecorvi, S Filetti, ... The Journal of Clinical Endocrinology & Metabolism 82 (3), 735-738, 1997 | 147 | 1997 |
| Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells E Tirro, ML Consoli, M Massimino, L Manzella, F Frasca, L Sciacca, ... Cancer research 66 (8), 4263-4272, 2006 | 141 | 2006 |
| HMGA1 inhibits the function of p53 family members in thyroid cancer cells F Frasca, A Rustighi, R Malaguarnera, S Altamura, P Vigneri, G Del Sal, ... Cancer research 66 (6), 2980-2989, 2006 | 129 | 2006 |
| Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients L Sciacca, R Vigneri, A Tumminia, F Frasca, S Squatrito, L Frittitta, ... Nutrition, Metabolism and Cardiovascular Diseases 23 (9), 808-815, 2013 | 117 | 2013 |
| Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic … M Breccia, R Latagliata, F Stagno, L Luciano, A Gozzini, F Castagnetti, ... Haematologica 96 (10), 1457, 2011 | 110 | 2011 |
